Search Within

Sujata Patil

  1. "Population Sciences Research Program"
Formats
  1. Meeting Abstract (70)
  2. Journal Article (55)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Biostatistics Service (127)
  2. Department of Medicine (127)
  3. Epidemiology and Biostatistics (127)
  4. Population Sciences Research Program (127)
  5. Solid Tumor Oncology Division (126)
  6. Survivorship Research (106)

More Groups

People
  1. Clifford Hudis (44)
  2. Shari Goldfarb (34)
  3. Mark Robson (32)
  4. Chau Dang (30)
  5. Larry Norton (29)
  6. Shanu Modi (25)

More People

Years
  1. 2023 (2)
  2. 2022 (6)
  3. 2021 (10)
  4. 2020 (17)
  5. 2019 (14)
  6. 2018 (10)

More Years

Publications
  1. Journal of Clinical Oncology (44)
  2. Cancer Research (18)
  3. Breast Cancer Research and Treatment (9)
  4. Cancer (7)
  5. The Oncologist (5)
  6. Annals of Surgical Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (45)
  2. American Association for Cancer Research (22)
  3. Springer (13)
  4. Elsevier Inc. (10)
  5. Wiley Blackwell (8)
  6. Oxford University Press (5)

More Publishers

Results (127)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase Ib study of BEZ235, a dual inhibitor of phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR), in patients with advanced renal cell carcinoma
    Journal Article

    Carlo, M. I.; Molina, A. M.; Lakhman, Y.; Patil, S.; Woo, K.; Deluca, J.; Lee, C. H.; Hsieh, J. J.; Feldman, D. R.; Motzer, R. J.; more...
    The Oncologist (2016)

    Fulltext@MSK | Save
  • Pathologic complete response rate with doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-positive early stage breast cancer: A single institution experience
    Meeting Abstract

    Singh, J. C.; Sugarman, S.; Jones, L.; Boafo, C.; Patil, S.; Schweber, S.; Yu, A.; Argolo, D.; Modi, S.; Iyengar, N.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Fertility preservation for the young breast cancer patient
    Journal Article

    Goldfarb, S. B.; Kamer, S. A.; Oppong, B. A.; Eaton, A.; Patil, S.; Junqueira, M. J.; Olcese, C.; Kelvin, J. F.; Gemignani, M. L.
    Annals of Surgical Oncology (2016)

    Fulltext@MSK | Save
  • Cardiac safety of paclitaxel plus trastuzumab and pertuzumab in patients with HER2-positive metastatic breast cancer
    Journal Article

    Yu, A. F.; Manrique, C.; Pun, S.; Liu, J. E.; Mara, E.; Fleisher, M.; Patil, S.; Jones, L. W.; Steingart, R. M.; Hudis, C. A.; more...
    The Oncologist (2016)

    Fulltext@MSK | Save
  • Twenty-one-gene recurrence score assay in BRCA-associated versus sporadic breast cancers: Differences based on germline mutation status
    Journal Article

    Shah, P. D.; Patil, S.; Dickler, M. N.; Offit, K.; Hudis, C. A.; Robson, M. E.
    Cancer (2016)

    Fulltext@MSK | Save
  • A pilot study of dose-dense paclitaxel with trastuzumab and lapatinib for node-negative HER2-overexpressed breast cancer
    Journal Article

    Iyengar, N. M.; Fornier, M. N.; Sugarman, S. M.; Theodoulou, M.; Troso-Sandoval, T. A.; D'Andrea, G. M.; Drullinsky, P. R.; Gajria, D.; Goldfarb, S. B.; Comen, E. A.; more...
    Clinical Breast Cancer (2016)

    Fulltext@MSK | Save
  • Phase I study of PI3Kα inhibitor BYL719 + aromatase inhibitor (AI) in patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Moynahan, M. E.; Modi, S.; Hamilton, N.; Caravella, B. A.; Zamora, S.; Dang, C.; Gilewski, T.; Traina, T.; Comen, E.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Phase II study of weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer (MBC): Updated progression-free survival with overall survival result
    Meeting Abstract

    Smyth, L. M.; Iyengar, N. M.; Chandarlapaty, S.; Sugarman, S.; Comen, E. A.; Drullinsky, P.; Sklarin, N. T.; Traina, T. A.; Troso-Sandoval, T. A.; Patil, S.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Oncotype DX in BRCA-associated vs. sporadic breast cancers: Differences based on germline mutation status and potential implications for adjuvant systemic therapy (AST)
    Meeting Abstract

    Shah, P. D.; Patil, S.; Dickler, M. N.; Offit, K.; Hudis, C. A.; Robson, M. E.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • The impact of adjuvant breast cancer (BC) chemotherapy on ovarian reserve and menses
    Meeting Abstract

    Goldfarb, S. B.; Bedoschi, G.; Grunblatt, E.; Goswami, S.; Cigler, T.; Quistorff, J.; Pacheco, F.; Stobezki, R.; Robson, M. E.; Moy, F.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save